Compare PRIM & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRIM | MMED |
|---|---|---|
| Founded | 1960 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.5B |
| IPO Year | 2006 | 2025 |
| Metric | PRIM | MMED |
|---|---|---|
| Price | $83.05 | $19.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $155.20 | $22.56 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 05-05-2026 | 06-03-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 51.66 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $9.92 | $15.99 |
| Revenue Next Year | $8.80 | $10.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $65.00 | $10.65 |
| 52 Week High | $205.50 | $20.88 |
| Indicator | PRIM | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 46.05 | 60.75 |
| Support Level | $76.99 | $10.68 |
| Resistance Level | $92.16 | N/A |
| Average True Range (ATR) | 4.54 | 0.82 |
| MACD | 0.58 | 0.01 |
| Stochastic Oscillator | 48.76 | 53.11 |
Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.